Autoantibodies in patients with IIM, i.e., myositis autoantibodies (MAs), can be further classified into myositis-specific autoantibodies (MSAs), detected uniquely in two of three patients with IIM presenting specific phenotypes (9) among each MSA and mutually exclusive to one another. Here, MAS1 is linked to myositis disease.